PD‐L1 expression in patients with non‐small‐cell lung cancer is associated with sex and genetic alterations: A retrospective study within the Caucasian population

Abstract Background Programmed cell death‐ligand 1 (PD‐L1) expression is a well‐established biomarker for predicting responses to immune checkpoint inhibitors and certain targeted therapies. As a result, treatment strategies for patients vary based on their PD‐L1 expression status. Understanding the...

ver descrição completa

Detalhes bibliográficos

Principais autores:	P. Sarova, B. Mosleh, S. Zehetmayer, F. Oberndorfer, J. Widder, H. Prosch, C. Aigner, M. Idzko, M. A. Hoda, D. Gompelmann
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Wiley 2024-07-01
Colecção:	Thoracic Cancer
Assuntos:	gender medicine genetic aberrations non‐small cell lung cancer PD‐L1 status
Acesso em linha:	https://doi.org/10.1111/1759-7714.15336
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!